Page last updated: 2024-08-21

androstenediol and Shock, Septic

androstenediol has been researched along with Shock, Septic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Auci, D; Frincke, J; Mangano, K; Morgan, L; Nicoletti, F; Nierkens, S; Offner, H; Pieters, R; Reading, C1
Ben-Nathan, D; Loria, RM; Padgett, DA1

Other Studies

2 other study(ies) available for androstenediol and Shock, Septic

ArticleYear
Anti-inflammatory and immune regulatory properties of 5-androsten-3beta, 17beta-diol (HE2100), and synthetic analogue HE3204: implications for treatment of autoimmune diseases.
    Annals of the New York Academy of Sciences, 2005, Volume: 1051

    Topics: Amino Acid Sequence; Androstenediol; Androstenols; Animals; Anti-Inflammatory Agents; Autoimmune Diseases; Encephalomyelitis, Autoimmune, Experimental; Female; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Pleurisy; Shock, Septic

2005
Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity.
    Journal of medical microbiology, 1999, Volume: 48, Issue:5

    Topics: Androstenediol; Animals; Dehydroepiandrosterone; Enterococcus faecalis; Female; Gram-Positive Bacterial Infections; Interleukin-1; Lipopolysaccharides; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Pseudomonas Infections; Shock, Septic; Tumor Necrosis Factor-alpha

1999